Intended Audience

Medical and Nursing, Scientists, Pharmacists,

Governance, Research, Lab

Further information

Fee FREE TO ATTEND* (T&C’s apply) Register www.www.christie.nhs.uk/soo-

events Email education.events@christie.nhs.uk Call 0161 918 7409 * Please note that if you book a place and fail to attend without giving at least 7 days notice of cancellation, a £20 cancellation fee will be applied.

An Overview of Advanced Therapies: The UK landscape

Tuesday 22nd October 2019 Education Centre (Dept 17), The Christie, Manchester, M20 4BX

Topics Covered

Malignant indications

Non Malignant Indications

Patient experience

Manufacturing issues

Commissioning of

ATMPs

Governance and Education

Toxicity Management

Overview

An overview of the current issues in the development and delivery of Advanced Therapies, Cell and Gene Therapy, Adoptive Cell Therapies and iMATCH. This study day will increase knowledge on the clinical indications of Advanced Therapies. Delegates will gain an understanding of the complexities of delivering Advanced Therapies in an NHS setting. This will increase awareness of the patient experience and perspective of Advanced Therapy Medicinal Products.

Follow us:

08:30 Registration & Coffee

09:00 Welcome

Dr Jacqueline Barry - Chief Clinical Officer, Cell and Gene Therapy Catapult

09:15 Introduction to iMatch

Dr Fiona Thistlethwaite - Medical Oncology Consultant Experimental Cancer Medicine Team (ECMT), IMATCH Director

09:30 Tumour Infiltrating Lymphocytes Exposed

Prof Roberts Hawkins - Chief Executive Officer and Co-founder of Cellular Therapeutics Ltd, Cellular Therapeutics Ltd

09:55 Cell and Gene Therapy in Paediatric Metabolic Diseases

Prof Robert Wynn - Consultant Paediatric Haematologist & Director of Paediatric Bone Marrow Transplant Programme

Beatriz Duran-Jimenez - Pharmacy Head of Research and Innovation, Manchester University NHS Foundation Trust

10:20 Patient experience of Advanced Therapies

10:45 Coffee Break

Delegates will need to select 1 breakout session from each time slot listed below (please select these through Eventbrite when booking):

11:00 A) What is driving CARTs into the spotlight?

Dr Adrian Bloor - Consultant Haematologist, The Christie

or B) Gene Therapy in Haemophilia

TBC

11:30 C) Oncology adoptive T-Cell therapy - the patient pathway

Tamara Garcia Lopez - Advanced Immune and Cell Therapy Team Leader, The Christie

Michelle Davies - Advanced Nurse Practitioner, The Christie

or D) Cell and Gene Therapy in Haemoglobinapathy

Bluebird

12:00 E) Advanced Therapies in Ophthalmology

TBC

or F) Gene and Cell Therapy in Sickle Cell

TBC

12:30 G) Oncolytic Virus Trial in Lung

Dr Paul Taylor - Pulmonary Oncology Consultant, Manchester University

NHS Foundation Trust

or H) Neurology - Spinal Muscular Atrophy

TBC

Parallel Sessions

An Overview of Advanced Immune Therapies:

The UK Landscape

Follow us:

Delegates will need to select 1 breakout session from each time slot listed below (please select these through Event-brite when booking):

13:45 I) Industry Prospective

TBC Neil Bell - Autoless CEO

or J) ITU considerations and escalation of care

Fiona Dignan - Consultant Haematologist, Manchester University NHS Foundation Trust

14:10 K) NHS England: Commissioning for ATMPs

TBC Steve Williamson - NHS England Lead Cancer Pharmacist

or L) JACIE readiness for Immune Effector Cells

Simon Cliffe - Quality Manager, The Christie

14:30 M) UKMi Horizon Scanning Service

Helen Davies - Director, North West Medicines Information Centre, SPS Horizon Scanning Lead

or N) Addition of ATIMPs onto an Electronic Prescribing System

Zahra Mahmood - Clinical Pharmacist, The Christie

14:50 O) Advanced Cell Therapy Manufacturing

Martine Thomas - GMP Production Manager, Immetacyte

or P) Introducing a Introducing a bespoke ATIMP education package

Michelle Davies - Advanced Nurse Practitioner, The Christie

Laura McNab - Senior Practice Facilitator, Advanced Immune and Cell Therapy, The Christie

15:15 Coffee Break

15:30 Delivery of ATIMPs in the NHS- Governance

Beatriz Duran-Jimenez - Pharmacy Head of Research and Innovation, Manchester University NHS Foundation Trust

Sophia Burgess - Clinical Trials Pharmacist, Manchester University NHS Foundation Trust

15:55 Catapult and ATTC network

Ian Hollingsworth - ATTC Programme Manager, Cell and Gene Therapy Catapult

16:15 Advanced Therapies Apprenticeship Community

Tony Bradshaw - Advanced Therapies Apprenticeships Community Team Project

16:30 Panel Discussion

Prof Fiona Thistlethwaite, Prof Robert Wynn, Michelle Davies, Beatriz Duran-Jimenez,

Dr Kim Linton

16:45 Summary and Close

17:00 Finish

Parallel Sessions Continued

Follow us:

An Overview of Advanced Immune Therapies:

The UK Landscape